Development of a micro-tissue-mediated injectable bone tissue engineering strategy for large segmental bone defect treatment

BACKGROUND: Bone tissue engineering is not widely used in clinical treatment. Two main reasons hide behind this: (1) the seed cells are difficult to obtain and (2) the process of tissue engineering bone construction is too complex and its efficiency is still relatively low. It is foreseeable that in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dingyu, Wang, Zhenxing, Wang, Jinbing, Geng, Yingnan, Zhang, Zhanzhao, Li, Yu, Li, Qiannan, Zheng, Zhiwei, Cao, Yilin, Zhang, Zhi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263540/
https://www.ncbi.nlm.nih.gov/pubmed/30486863
http://dx.doi.org/10.1186/s13287-018-1064-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263540/
https://www.ncbi.nlm.nih.gov/pubmed/30486863
http://dx.doi.org/10.1186/s13287-018-1064-1

Ejemplares similares